Drug giant AstraZeneca will expand its biologics manufacturing center in Frederick and add hundreds of jobs to its operations there.
The drug giant will spend more than $200 million to increase production capacity. MedImmune, AstraZeneca’s biologics research and development arm, has more than 120 drugs in its research pipeline, including more than 30 in clinical development. AstraZeneca says the expansion will support its research.
Local companies, along with County Executive Leggett, are exploring incredible international business opportunities in the Indian market as part of the County’s business mission to India November 13 through 22. Read the press release to learn more.
Few businesses owned by venture capital firms have been awarded Small Business Innovation Research awards since this program was opened to them two years ago.
Through the SBIR program, 11 federal agencies spend at least 2.8 percent of their outside research budgets with small businesses. Only two of these agencies — the National Institutes of Health and the Advanced Research Projects Agency-Energy — have allowed VC-owned businesses to compete for SBIR awards, according to a new Government Accountability Office study.
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association for life science and technology, today announced that it will honor former Lockheed Martin Corporation Chairman and CEO Norman Augustine, MedImmune, Inc. Founder Dr. Wayne Hockmeyer and University System of Maryland Chancellor William Kirwan with its 2015 Lifetime Achievement Awards. The awards will be presented during TCM’s Lifetime Achievement Gala, February 19, 2015.
That was the theme when medical thought leaders converged on New York City recently for the Faster Cures Center of the Milken Institute’s “Partnering for Cures” conference where Fox News’ own Dr. Manny Alvarez was a panel moderator.
Health tech incubator MATTER has secured $4.4 million to build the next generation of health IT, medical device, diagnostics and biopharma companies in Chicago. The funding was led by twenty two local companies mostly focused in the tech and healthcare sectors complementing the initial $2.5M grant and $1.5M loan provided by the State of Illinois. This brings MATTER’s total funding to more than $8M to build a viable health tech hub in Chicago.
Surgery is an art form for Johns Hopkins surgeon Dr. Amir Dorafshar, who on a November morning spent four hours smoothing the point out of a child’s skull.
The procedure, needed to allow the 18-month old’s brain to grow properly and avoid developmental disorders, requires taking apart the skull in pieces, then putting it back together.
Unlock your molecule’s potential with the help of EMD Millipore’s Emerging Biotech Grant Program
At EMD Millipore, it’s our goal to help advance lifesaving drugs to market. We understand the challenges that emerging biotech companies face in their quest to quickly push the next generation of drugs to market. We want to help you succeed.
Baltimore biotech firm Noxilizer Inc. is expanding its footprint at the University of Maryland BioPark to meet growing demand from clients.
Noxilizer developed a medical sterilization system that uses nitrogen dioxide, a faster alternative to traditional methods. The company added about 5,000 square feet to its sterilization space to accommodate a growing interest in its contract sterilization services. The company’s sterilization lab now takes up about 16,00 square feet — the entire basement at 801 W. Baltimore Street.
In perhaps yet another sign of the expanding role of retail healthcare, CVS Health said it is opening a new Digital Innovation Hub on Boston that will serve as a central hub for the Rhode Island-based pharmacy’s digital health team.
